ES8603185A1 - Procedimiento para preparar 9-(propoximetil monosubstituido en 1-0 o en 3-0 o di-substituido en 1,3-0)-purinas substituidas como agentes antivirales - Google Patents
Procedimiento para preparar 9-(propoximetil monosubstituido en 1-0 o en 3-0 o di-substituido en 1,3-0)-purinas substituidas como agentes antiviralesInfo
- Publication number
- ES8603185A1 ES8603185A1 ES524811A ES524811A ES8603185A1 ES 8603185 A1 ES8603185 A1 ES 8603185A1 ES 524811 A ES524811 A ES 524811A ES 524811 A ES524811 A ES 524811A ES 8603185 A1 ES8603185 A1 ES 8603185A1
- Authority
- ES
- Spain
- Prior art keywords
- virus
- herpes
- carbon atoms
- nr9r10
- azido
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/17—Unsaturated ethers containing halogen
- C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
- C07C43/1745—Unsaturated ethers containing halogen containing six-membered aromatic rings having more than one ether bound
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
- C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
PROCEDIMIENTO PARA PREPARAR 9-(PROPOXIMETIL MONOSUSTITUIDO EN 1-O O EN 3-O O DISUSTITUIDO EN 1,3-O)-PURINAS SUSTITUIDAS COMO AGENTES ANTIVIRALES. COMPRENDE: A) HACER REACCIONAR UN COMPUESTO DE FORMULA (II), CON R7OH EN UN DISOLVENTE, COMO N,N-DIMETILFORMAMIDA Y OTROS, A UNA TEMPERATURA DE 45 A 65JC, Y CON AGITACION; Y B) ELIMINAR EL DISOLVENTE Y HACER REACCIONAR EL COMPUESTO (II) CON UN ALCOHOL O AMINA EN PRESENCIA DE UN CATALIZADOR, COMO 4-DIMETILAMINOPIRIDINA A UNA TEMPERATURA DE 50 A 200JC, PARA OBTENER UN COMPUESTO DE FORMULA (I) POR CROMATOGRAFIA. SIENDO: R1 Y R2-C(-Y) OR7; R3 ES H, HALO Y OTROS; R4 Y R5 SON UN ENLACE; R6 ES H, HALO, ALCOXI INFERIOR CON C 1 A 6 Y OTROS; R7 ES ALCOHILO CON C 1 A 12, ALQUELINO CON C 2 A 12 Y OTROS; W ES H O 1-CARBONILIMIDAZOL; WA ES 1-CARBONILIMIDAZOL. SE UTILIZA COMO AGENTE ANTIVIRAL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/406,583 US4556659A (en) | 1982-08-09 | 1982-08-09 | Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8603185A1 true ES8603185A1 (es) | 1986-01-01 |
ES524811A0 ES524811A0 (es) | 1986-01-01 |
Family
ID=23608623
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES524811A Granted ES524811A0 (es) | 1982-08-09 | 1983-08-08 | Procedimiento para preparar 9-(propoximetil monosubstituido en 1-0 o en 3-0 o di-substituido en 1,3-0)-purinas substituidas como agentes antivirales |
ES545261A Expired ES8603186A1 (es) | 1982-08-09 | 1985-07-16 | Procedimiento para preparar 9-(propoximetil monosubstituido en 1-0 o en 3-0 o di-substituido en 1,3-0)-purinas substi- tuido en 1,3-0)-purinas substituidas como agentes antivira- les |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES545261A Expired ES8603186A1 (es) | 1982-08-09 | 1985-07-16 | Procedimiento para preparar 9-(propoximetil monosubstituido en 1-0 o en 3-0 o di-substituido en 1,3-0)-purinas substi- tuido en 1,3-0)-purinas substituidas como agentes antivira- les |
Country Status (15)
Country | Link |
---|---|
US (1) | US4556659A (es) |
EP (1) | EP0105135B1 (es) |
JP (1) | JPS5948483A (es) |
KR (1) | KR890000811B1 (es) |
AT (1) | ATE25980T1 (es) |
AU (1) | AU571451B2 (es) |
DE (1) | DE3370331D1 (es) |
DK (1) | DK361383A (es) |
ES (2) | ES524811A0 (es) |
FI (1) | FI74006C (es) |
HU (1) | HU193530B (es) |
IE (1) | IE55843B1 (es) |
NO (1) | NO162469C (es) |
NZ (1) | NZ205171A (es) |
ZA (1) | ZA835799B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816447A (en) * | 1981-08-26 | 1989-03-28 | Merck & Co., Inc. | Anti-viral guanine compounds |
US4609661A (en) * | 1982-08-09 | 1986-09-02 | Syntex (U.S.A.) Inc. | Substituted 9-(1-O- or 3-O-monosubstituted or 1,3-di-O-substituted propoxymethyl)purines as antiviral agents |
ATE33653T1 (de) * | 1982-10-14 | 1988-05-15 | Wellcome Found | Antivirale purinderivate. |
US4880820A (en) * | 1983-06-24 | 1989-11-14 | Merck & Co., Inc. | Guanine derivatives |
US4897479A (en) * | 1983-09-30 | 1990-01-30 | Merck & Co., Inc. | Arylsulfonyloxy purine intermediates |
SE8406538D0 (sv) * | 1984-12-21 | 1984-12-21 | Astra Laekemedel Ab | Novel derivatives of purine |
US4642346A (en) * | 1985-06-24 | 1987-02-10 | Syntex (U.S.A.) Inc. | Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine |
GB8904855D0 (en) * | 1989-03-03 | 1989-04-12 | Beecham Group Plc | Pharmaceutical treatment |
DE4002792A1 (de) * | 1990-01-31 | 1991-08-01 | Teves Gmbh Alfred | Vorrichtung zur ermittlung der beschaffenheit einer druckuebertragungsfluessigkeit |
GB2260319B (en) | 1991-10-07 | 1995-12-06 | Norsk Hydro As | Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity |
CN110026212B (zh) * | 2019-05-23 | 2022-03-04 | 临海市利民化工有限公司 | 一种裂解催化剂及使用该催化剂制备西他沙星中间体的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4199574A (en) * | 1974-09-02 | 1980-04-22 | Burroughs Wellcome Co. | Methods and compositions for treating viral infections and guanine acyclic nucleosides |
AT380252B (de) * | 1981-08-11 | 1986-05-12 | Wellcome Found | Verfahren zur herstellung von neuen guanin- und 2,6-diaminopurinderivaten und ihren salzen |
NZ201662A (en) * | 1981-08-26 | 1986-07-11 | Merck & Co Inc | 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation |
-
1982
- 1982-08-09 US US06/406,583 patent/US4556659A/en not_active Expired - Fee Related
-
1983
- 1983-08-08 DE DE8383107818T patent/DE3370331D1/de not_active Expired
- 1983-08-08 AT AT83107818T patent/ATE25980T1/de active
- 1983-08-08 NZ NZ205171A patent/NZ205171A/en unknown
- 1983-08-08 HU HU832792A patent/HU193530B/hu not_active IP Right Cessation
- 1983-08-08 AU AU17683/83A patent/AU571451B2/en not_active Ceased
- 1983-08-08 NO NO832842A patent/NO162469C/no unknown
- 1983-08-08 ES ES524811A patent/ES524811A0/es active Granted
- 1983-08-08 JP JP58144857A patent/JPS5948483A/ja active Pending
- 1983-08-08 KR KR1019830003708A patent/KR890000811B1/ko not_active IP Right Cessation
- 1983-08-08 EP EP83107818A patent/EP0105135B1/en not_active Expired
- 1983-08-08 FI FI832832A patent/FI74006C/fi not_active IP Right Cessation
- 1983-08-08 DK DK361383A patent/DK361383A/da not_active Application Discontinuation
- 1983-08-08 IE IE1867/83A patent/IE55843B1/xx unknown
- 1983-08-08 ZA ZA835799A patent/ZA835799B/xx unknown
-
1985
- 1985-07-16 ES ES545261A patent/ES8603186A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE3370331D1 (en) | 1987-04-23 |
AU1768383A (en) | 1984-02-16 |
NZ205171A (en) | 1987-05-29 |
FI74006B (fi) | 1987-08-31 |
EP0105135A1 (en) | 1984-04-11 |
KR840006007A (ko) | 1984-11-21 |
EP0105135B1 (en) | 1987-03-18 |
ES545261A0 (es) | 1986-01-01 |
HU193530B (en) | 1987-10-28 |
NO832842L (no) | 1984-02-10 |
KR890000811B1 (ko) | 1989-04-08 |
JPS5948483A (ja) | 1984-03-19 |
AU571451B2 (en) | 1988-04-21 |
FI832832A (fi) | 1984-02-10 |
DK361383D0 (da) | 1983-08-08 |
ZA835799B (en) | 1984-04-25 |
FI74006C (fi) | 1987-12-10 |
NO162469B (no) | 1989-09-25 |
FI832832A0 (fi) | 1983-08-08 |
DK361383A (da) | 1984-02-10 |
IE831867L (en) | 1984-02-09 |
ES524811A0 (es) | 1986-01-01 |
NO162469C (no) | 1990-01-10 |
ATE25980T1 (de) | 1987-04-15 |
IE55843B1 (en) | 1991-01-30 |
US4556659A (en) | 1985-12-03 |
ES8603186A1 (es) | 1986-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8603186A1 (es) | Procedimiento para preparar 9-(propoximetil monosubstituido en 1-0 o en 3-0 o di-substituido en 1,3-0)-purinas substi- tuido en 1,3-0)-purinas substituidas como agentes antivira- les | |
ES8504194A1 (es) | Procedimiento para preparar 9-(1 o 3-monoaciloxi-o 1,3-diaciloxi-2-propoximetil)-purinas substituidas en calidad de agentes antiviricos. | |
BR1100846A (pt) | Composto, e, composição antiviral útil e processo para tratar o vìrus do herpes simples 1 e 2, vìrus varicella zoster e citomegalovìrus humano | |
PL136332B1 (en) | Process for preparing novel 9-/1,3-dihydroxy-2-propoxymethyl/-guanine | |
YU41884B (en) | Process for obtaining 6-substituted 9-hydroxy-alkyl purines | |
JPS6422813A (en) | Antiphlegmonic slimming cosmetics containing 1-hydroxyalkylxanthin | |
US4609661A (en) | Substituted 9-(1-O- or 3-O-monosubstituted or 1,3-di-O-substituted propoxymethyl)purines as antiviral agents | |
AU2631188A (en) | 9-(2-(Phosphonomethoxy)Ethoxy) Purine derivatives, intermediates and use as pharmaceuticals | |
US4612314A (en) | Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent | |
AU8441382A (en) | Antiviral alpha alpha dialkyl adamantylethylamines | |
US4603219A (en) | 1,3-dibenzyloxy-2-acetoxymethoxypropane, intermediate for 9-(1,3-dihydroxy-2-propoxymethyl)guanine | |
ES8501416A1 (es) | 5'-alquil o alquenil-fosfatos de nucleosidos. | |
US4507305A (en) | 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent | |
EP0157415A3 (en) | Pyrazolo[4,3-d] pyrimidine derivative process for its production antihyperlipidemic agent containing it, its intermediate, and process for the production of the intermediate | |
NZ205802A (en) | Phosphate ester derivatives of guanine as antiviral agents | |
HUT37771A (en) | Process for preparing new 1,2,4-thiadiazones | |
US4803271A (en) | Process for preparing guanine derivatives | |
ES8505680A1 (es) | Procedimiento para preparar 9-(1 o 3-monoaciloxi-o 1,3-diaciloxi-2-propoximetil)-purinas substituidas en calidad de agentes antiviricos. | |
KR950703976A (ko) | 아시클로비르 유사 화합물과 2′-비닐 치환 뉴클레오시드 유사체를 함유하는 바이러스 감염 치료용 조성물(Compositions Containing Acyclovir-Like Compounds and 2′-Vinyl substituted Nucleoside Analogs for the Treatment of Viral Infections) | |
NZ234918A (en) | 2-amino purine or guanine derivatives and antiviral compositions containing such; pyrimidine and substituted hydroxylamine intermediates | |
ES8704171A1 (es) | Un procedimiento para la preparacion de piridazino (4,5-b)indoles | |
ES8604588A1 (es) | Un procedimiento para preparar 2-amino-9-(2-hidroxi-etoximetil) purina | |
ES2065234B1 (es) | Compuestos para tratar enfermedades relacionadas con los leucotrienos. | |
YU45817B (sh) | Postopek za pripravo substituiranih 9-(1- ali 3-monoaciloksi ali 1-3-diaciloksi-2-propoksimetil)purinov kot antivirusnih sredstev |